# Irreversible Electroporation (NanoKnife) for the Treatment of Pancreatic Adenocarcinoma

> **NCT03105921** · NA · COMPLETED · sponsor: **Poitiers University Hospital** · enrollment: 20 (actual)

## Conditions studied

- Pancreatic Adenocarcinoma
- Interventional Imaging

## Interventions

- **DEVICE:** NanoKnife

## Key facts

- **NCT ID:** NCT03105921
- **Lead sponsor:** Poitiers University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-10-24
- **Primary completion:** 2021-04-01
- **Final completion:** 2021-04-01
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2022-03-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03105921

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03105921, "Irreversible Electroporation (NanoKnife) for the Treatment of Pancreatic Adenocarcinoma". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03105921. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*